On April 24, 2017, Foresite Capital revealed that they had named Molly He as venture partner. Dr. He was a senior director at Illumina. She has over 15 years of experience in the pharmaceutical and genomic sector.
Jim Tananbaum, the C.E.O and MD of Foresite Capital, stated that the company is thrilled to welcome Dr. He. Jim added that He’s remarkable leadership track record and expertise in genomics will be a great resource to Foresite.
While Molly He, Ph.D., worked at Illumina, she was responsible for the global protein improvements and innovation in the company. Before she joined Illumina, she worked at Pacific Bioscience. There, she was tasked with the responsibility of developing protein reagent for the firm and his Facebook.
He spent the earlier years of her career focusing on the structural design of antibody and drugs that target immune diseases and cancer. She has authored over 20 published papers. In addition, she owns applications and patents in the sequencing and personalized medicine sector. Molly He holds a doctorate degree in protein biophysics and more information click here.
In Foresite’s press release, Dr. He praised Foresite Capital for having a great reputation in investing in innovative and exciting healthcare providers. She added that she’s honored to join Foresite as she will help grow the next-generation sequencing of the company. Dr. Molly He insists that next-generation sequencing has the capacity to bring about the next series of the breakthrough in drug discovery and clinical study.
About Jim Tananbaum
Recently, Jim Tananbaum was included on the Midas List for the third year in a row. The Forbes’ Midas list comprises of 100 top venture capitalists who invest in the leading tech firms. This year Jim was ranked 54th.
Tananbaum is Foresight Capital’s founder. He aims to build several health care franchises. His work at Foresight is to create an investment strategy and identify financial and operational opportunities.
Over the last couple of decades, Jim Tananbaum has helped grow franchise healthcare businesses in various medical sectors. He co-founded Prospect Venture Partners, GelTex Pharmaceuticals, and Theravance, Inc.
His company, Foresite Capital, focuses on providing capital to upcoming healthcare leaders. The company has an office in New York and is headquartered in San Francisco.
More visit: https://twitter.com/foresitecap